Toll Free: 1-888-928-9744

Global Metabolic Syndrome Market Size, Status and Forecast 2018-2025

Published: Aug, 2018 | Pages: 100 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report focuses on the global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Syndrome development in United States, Europe and China.

Metabolic syndrome is a cluster of conditions - increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels - that occur together, increasing your risk of heart disease, stroke and diabetes.
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.
In 2017, the global Metabolic Syndrome market size was 24600 million US$ and it is expected to reach 36700 million US$ by the end of 2025, with a CAGR of 5.1% during 2018-2025.

The key players covered in this study
    Novo Nordisk
    Sanofi
    Merck
    AstraZeneca
    Eli Lily
    AbbVie
    Actelion Pharmaceuticals
    Adocia
    Aegerion Pharmaceuticals
    Akros Pharma
    Alnylam Pharmaceuticals
    Amarin
    nAmgen
    Amicus Therapeutics
    Arbutus Biopharma

Market segment by Type, the product can be split into
    Diabetes
    Obesity
    Hypercholesterolemia
    Lysosomal storage diseases

Market segment by Application, split into
    Hospital
    Clinic
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players.
    To present the Metabolic Syndrome development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metabolic Syndrome are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Metabolic Syndrome Market Size Growth Rate by Type (2013-2025)
        1.4.2 Diabetes
        1.4.3 Obesity
        1.4.4 Hypercholesterolemia
        1.4.5 Lysosomal storage diseases
    1.5 Market by Application
        1.5.1 Global Metabolic Syndrome Market Share by Application (2013-2025)
        1.5.2 Hospital
        1.5.3 Clinic
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Metabolic Syndrome Market Size
    2.2 Metabolic Syndrome Growth Trends by Regions
        2.2.1 Metabolic Syndrome Market Size by Regions (2013-2025)
        2.2.2 Metabolic Syndrome Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Metabolic Syndrome Market Size by Manufacturers
        3.1.1 Global Metabolic Syndrome Revenue by Manufacturers (2013-2018)
        3.1.2 Global Metabolic Syndrome Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Metabolic Syndrome Market Concentration Ratio (CR5 and HHI)
    3.2 Metabolic Syndrome Key Players Head office and Area Served
    3.3 Key Players Metabolic Syndrome Product/Solution/Service
    3.4 Date of Enter into Metabolic Syndrome Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Metabolic Syndrome Market Size by Type (2013-2018)
    4.2 Global Metabolic Syndrome Market Size by Application (2013-2018)

5 United States
    5.1 United States Metabolic Syndrome Market Size (2013-2018)
    5.2 Metabolic Syndrome Key Players in United States
    5.3 United States Metabolic Syndrome Market Size by Type
    5.4 United States Metabolic Syndrome Market Size by Application

6 Europe
    6.1 Europe Metabolic Syndrome Market Size (2013-2018)
    6.2 Metabolic Syndrome Key Players in Europe
    6.3 Europe Metabolic Syndrome Market Size by Type
    6.4 Europe Metabolic Syndrome Market Size by Application

7 China
    7.1 China Metabolic Syndrome Market Size (2013-2018)
    7.2 Metabolic Syndrome Key Players in China
    7.3 China Metabolic Syndrome Market Size by Type
    7.4 China Metabolic Syndrome Market Size by Application

8 Japan
    8.1 Japan Metabolic Syndrome Market Size (2013-2018)
    8.2 Metabolic Syndrome Key Players in Japan
    8.3 Japan Metabolic Syndrome Market Size by Type
    8.4 Japan Metabolic Syndrome Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Metabolic Syndrome Market Size (2013-2018)
    9.2 Metabolic Syndrome Key Players in Southeast Asia
    9.3 Southeast Asia Metabolic Syndrome Market Size by Type
    9.4 Southeast Asia Metabolic Syndrome Market Size by Application

10 India
    10.1 India Metabolic Syndrome Market Size (2013-2018)
    10.2 Metabolic Syndrome Key Players in India
    10.3 India Metabolic Syndrome Market Size by Type
    10.4 India Metabolic Syndrome Market Size by Application

11 Central & South America
    11.1 Central & South America Metabolic Syndrome Market Size (2013-2018)
    11.2 Metabolic Syndrome Key Players in Central & South America
    11.3 Central & South America Metabolic Syndrome Market Size by Type
    11.4 Central & South America Metabolic Syndrome Market Size by Application

12 International Players Profiles
    12.1 Novo Nordisk
        12.1.1 Novo Nordisk Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Metabolic Syndrome Introduction
        12.1.4 Novo Nordisk Revenue in Metabolic Syndrome Business (2013-2018)
        12.1.5 Novo Nordisk Recent Development
    12.2 Sanofi
        12.2.1 Sanofi Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Metabolic Syndrome Introduction
        12.2.4 Sanofi Revenue in Metabolic Syndrome Business (2013-2018)
        12.2.5 Sanofi Recent Development
    12.3 Merck
        12.3.1 Merck Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Metabolic Syndrome Introduction
        12.3.4 Merck Revenue in Metabolic Syndrome Business (2013-2018)
        12.3.5 Merck Recent Development
    12.4 AstraZeneca
        12.4.1 AstraZeneca Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Metabolic Syndrome Introduction
        12.4.4 AstraZeneca Revenue in Metabolic Syndrome Business (2013-2018)
        12.4.5 AstraZeneca Recent Development
    12.5 Eli Lily
        12.5.1 Eli Lily Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Metabolic Syndrome Introduction
        12.5.4 Eli Lily Revenue in Metabolic Syndrome Business (2013-2018)
        12.5.5 Eli Lily Recent Development
    12.6 AbbVie
        12.6.1 AbbVie Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Metabolic Syndrome Introduction
        12.6.4 AbbVie Revenue in Metabolic Syndrome Business (2013-2018)
        12.6.5 AbbVie Recent Development
    12.7 Actelion Pharmaceuticals
        12.7.1 Actelion Pharmaceuticals Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Metabolic Syndrome Introduction
        12.7.4 Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)
        12.7.5 Actelion Pharmaceuticals Recent Development
    12.8 Adocia
        12.8.1 Adocia Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Metabolic Syndrome Introduction
        12.8.4 Adocia Revenue in Metabolic Syndrome Business (2013-2018)
        12.8.5 Adocia Recent Development
    12.9 Aegerion Pharmaceuticals
        12.9.1 Aegerion Pharmaceuticals Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Metabolic Syndrome Introduction
        12.9.4 Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)
        12.9.5 Aegerion Pharmaceuticals Recent Development
    12.10 Akros Pharma
        12.10.1 Akros Pharma Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Metabolic Syndrome Introduction
        12.10.4 Akros Pharma Revenue in Metabolic Syndrome Business (2013-2018)
        12.10.5 Akros Pharma Recent Development
    12.11 Alnylam Pharmaceuticals
    12.12 Amarin
    12.13 nAmgen
    12.14 Amicus Therapeutics
    12.15 Arbutus Biopharma

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
List of Tables and Figures

    Table Metabolic Syndrome Key Market Segments
    Table Key Players Metabolic Syndrome Covered
    Table Global Metabolic Syndrome Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Metabolic Syndrome Market Size Market Share by Type 2013-2025
    Figure Diabetes Figures
    Table Key Players of Diabetes
    Figure Obesity Figures
    Table Key Players of Obesity
    Figure Hypercholesterolemia Figures
    Table Key Players of Hypercholesterolemia
    Figure Lysosomal storage diseases Figures
    Table Key Players of Lysosomal storage diseases
    Table Global Metabolic Syndrome Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospital Case Studies
    Figure Clinic Case Studies
    Figure Others Case Studies
    Figure Metabolic Syndrome Report Years Considered
    Table Global Metabolic Syndrome Market Size 2013-2025 (Million US$)
    Figure Global Metabolic Syndrome Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Metabolic Syndrome Market Size by Regions 2013-2025 (Million US$)
    Table Global Metabolic Syndrome Market Size by Regions 2013-2018 (Million US$)
    Table Global Metabolic Syndrome Market Share by Regions 2013-2018
    Figure Global Metabolic Syndrome Market Share by Regions 2013-2018
    Figure Global Metabolic Syndrome Market Share by Regions 2018
    Table Market Top Trends
    Table Global Metabolic Syndrome Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Metabolic Syndrome Market Share by Manufacturers (2013-2018)
    Figure Global Metabolic Syndrome Market Share by Manufacturers in 2018
    Table Global Metabolic Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Metabolic Syndrome Product/Solution/Service
    Table Date of Enter into Metabolic Syndrome Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table Global Metabolic Syndrome Market Size Share by Type (2013-2018)
    Figure Global Metabolic Syndrome Market Size Market Share by Type (2013-2018)
    Table Global Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table Global Metabolic Syndrome Market Size Share by Application (2013-2018)
    Figure Global Metabolic Syndrome Market Size Market Share by Application (2013-2018)
    Figure Global Metabolic Syndrome Revenue Market Share by Application in 2017
    Figure United States Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table United States Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table United States Key Players Metabolic Syndrome Market Share (2017-2018)
    Table United States Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table United States Metabolic Syndrome Market Share by Type (2013-2018)
    Table United States Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table United States Metabolic Syndrome Market Share by Application (2013-2018)
    Figure Europe Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table Europe Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table Europe Key Players Metabolic Syndrome Market Share (2017-2018)
    Table Europe Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table Europe Metabolic Syndrome Market Share by Type (2013-2018)
    Table Europe Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table Europe Metabolic Syndrome Market Share by Application (2013-2018)
    Figure China Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table China Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table China Key Players Metabolic Syndrome Market Share (2017-2018)
    Table China Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table China Metabolic Syndrome Market Share by Type (2013-2018)
    Table China Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table China Metabolic Syndrome Market Share by Application (2013-2018)
    Figure Japan Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table Japan Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table Japan Key Players Metabolic Syndrome Market Share (2017-2018)
    Table Japan Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table Japan Metabolic Syndrome Market Share by Type (2013-2018)
    Table Japan Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table Japan Metabolic Syndrome Market Share by Application (2013-2018)
    Figure Southeast Asia Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Metabolic Syndrome Market Share (2017-2018)
    Table Southeast Asia Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Metabolic Syndrome Market Share by Type (2013-2018)
    Table Southeast Asia Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Metabolic Syndrome Market Share by Application (2013-2018)
    Figure India Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table India Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table India Key Players Metabolic Syndrome Market Share (2017-2018)
    Table India Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table India Metabolic Syndrome Market Share by Type (2013-2018)
    Table India Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table India Metabolic Syndrome Market Share by Application (2013-2018)
    Figure Central & South America Metabolic Syndrome Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Metabolic Syndrome Market Share (2017-2018)
    Table Central & South America Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Metabolic Syndrome Market Share by Type (2013-2018)
    Table Central & South America Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Metabolic Syndrome Market Share by Application (2013-2018)
    Table Novo Nordisk Company Details
    Table Novo Nordisk Revenue in Metabolic Syndrome Business (2013-2018) (Million US$)
    Figure Novo Nordisk Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Novo Nordisk Recent Development
    Table Sanofi Company Details
    Table Sanofi Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Sanofi Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Sanofi Recent Development
    Table Merck Company Details
    Table Merck Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Merck Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Merck Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure AstraZeneca Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table AstraZeneca Recent Development
    Table Eli Lily Company Details
    Table Eli Lily Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Eli Lily Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Eli Lily Recent Development
    Table AbbVie Company Details
    Table AbbVie Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure AbbVie Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table AbbVie Recent Development
    Table Actelion Pharmaceuticals Company Details
    Table Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Actelion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Actelion Pharmaceuticals Recent Development
    Table Adocia Company Details
    Table Adocia Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Adocia Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Adocia Recent Development
    Table Aegerion Pharmaceuticals Company Details
    Table Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Aegerion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Aegerion Pharmaceuticals Recent Development
    Table Akros Pharma Company Details
    Table Akros Pharma Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
    Figure Akros Pharma Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
    Table Akros Pharma Recent Development
    Table Alnylam Pharmaceuticals Company Details
    Table Amarin Company Details
    Table nAmgen Company Details
    Table Amicus Therapeutics Company Details
    Table Arbutus Biopharma Company Details
    Table Global Metabolic Syndrome Market Size by Regions (Million US$) 2018-2025
    Figure Global Metabolic Syndrome Market Size Share by Regions (2018-2025)
    Figure Global Metabolic Syndrome Market Size Share by Regions in 2025
    Figure United States Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Figure China Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Figure India Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
    Table Global Metabolic Syndrome Market Size by Product (2018-2025) (Million US$)
    Figure Global Metabolic Syndrome Market Size by Product (2018-2025)
    Figure Global Metabolic Syndrome Market Size by Product in 2025
    Table Global Metabolic Syndrome Market Size by Application (2018-2025) (Million US$)
    Figure Global Metabolic Syndrome Market Size by Application (2018-2025)
    Figure Global Metabolic Syndrome Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3900
Multi User - US $7800
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify